Oncology: the disease, dynamics & challenges of market research

The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.

Oncology: the disease, dynamics & challenges of market research | Ipsos

In such a fast-paced and multi-faceted environment, what are the key considerations for those working in oncology today?

In an update of our 2018 edition of this paper, we combine new data from Ipsos’ Global Oncology Monitor with our current therapy expertise and market insight to outline the considerations and challenges for professionals who market, or conduct marketing research for, oncology products.

 

The fundamentals of the disease and the complexity of its treatment are discussed, as well as specific developments such as biomarker testing, the ongoing rise of immunotherapy and biosimilars and, of course, more recent impacts from the global COVID-19 pandemic.

Download

More insights about Health

Related news

  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?
  • [Webinar] KEYS: What can we learn from what happened in 2025?
    Brand Image Webinar

    [Webinar] KEYS: What can we learn from what happened in 2025?

    In this final KEYS webinar of the year, we’ll be looking at the last 12 months through the rear-view mirror.
  • [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?
    Society Webinar

    [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?

    At our next KEYS webinar, we’ll be sharing on-the-ground perspectives as people give us their in-the-moment takes on how they see their lives - and their status in life - these days. Along the way we’ll hear about freedom (in the US), familismo (in Mexico) and understatedness (in the UK).